Key result
Four residues (Lys65, His66, Tyr71, Arg73) within exosite I mediate fibrin binding, and a DNA thrombin aptamer targeting these residues successfully inhibited the thrombin-fibrin interaction.
Answers are grounded in this paper and cite their sources.
Four specific residues within exosite I of thrombin mediate its interaction with fibrin, an interaction that can be inhibited by a targeted DNA aptamer.
Thrombin binding to fibrin may be important in localizing thrombin to the site of vascular injury. However, fibrin-bound thrombin retains its catalytic activity toward fibrinogen, and may be prothrombotic under certain conditions. A collection of 52 purified thrombin mutants was used to identify those residues mediating the thrombin-fibrin interaction. Comparison of fibrinogen clotting activity with fibrin binding activity identified twenty residues involved in fibrinogen recognition with four of these residues important in fibrin binding (Lys65, His66, Tyr71, Arg73). No mutant was identified with normal clotting activity and deficient fibrin binding, suggesting that these two properties are not readily dissociable. A DNA thrombin aptamer that binds to these residues was able to inhibit the thrombin-fibrin interaction, and displace thrombin that was already bound. Mapping of these fibrin-binding residues on thrombin revealed that they are localized within exosite I, and comprise a subset of the residues important in fibrinogen recognition.
No takes yet. Share an insight, caveat, or question.
Hall et al. (2001) studied this question. Thrombin mutants and DNA thrombin aptamer was evaluated on Fibrinogen clotting activity and fibrin binding activity. Four residues (Lys65, His66, Tyr71, Arg73) within exosite I mediate fibrin binding, and a DNA thrombin aptamer targeting these residues successfully inhibited the thrombin-fibrin interaction.
Synapse has enriched 10 related papers. Consider them for comparative context: